Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is a 25% decrease from the number of companies inspected in the previous quarter, when four companies received four inspections.
The companies inspected were involved in the Biologics sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Eastern Colorado Health Care System | Biologics | 02/29/2024 | No Action Indicated (NAI) |
| Rocky Mountain Tissue Bank | Biologics | 03/04/2024 | No Action Indicated (NAI) |
| Vitalant | Biologics | 02/15/2024 | No Action Indicated (NAI) |
Alerts Sign-up